HFE hemochromatosis: an overview about therapeutic recommendations
Hematol., Transfus. Cell Ther. (Impr.)
;
44(1): 95-99, Jan.-Mar. 2022. tab
Article
Dans Anglais
| LILACS
| ID: biblio-1364881
ABSTRACT
Abstract Hemochromatosis is currently characterized by the iron overload caused by hepcidin deficiency. Large advances in the knowledge on the hemochromatosis pathophysiology have occurred due to a better understanding of the protein of the iron metabolism, the genetic basis of hemochromatosis and of other iron overload diseases or conditions which can lead to this phenotype. In the present review, the main aims are to show updates on hemochromatosis and to report a practical set of therapeutic recommendations for the human factors engineering protein (HFE) hemochromatosis for the p.Cys282Tyr (C282Y/C282Y) homozygous genotype, elaborated by the Haemochromatosis International Taskforce.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Troubles du métabolisme du fer
/
Hémochromatose
Type d'étude:
Guide de pratique
Limites du sujet:
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Hematol., Transfus. Cell Ther. (Impr.)
Thème du journal:
Hematologia
/
TransfusÆo de Sangue
Année:
2022
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Santa Casa de São Paulo/BR
/
Universidade Federal de São Paulo - UNIFESP/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS